(Q39251189)

10 September 2017

Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? (English)

1 reference

10 September 2017

0 references

0 references

0 references

Miller DH

1

1 reference

10 September 2017

Hammond SR

2

1 reference

10 September 2017

McLeod JG

3

1 reference

10 September 2017

Purdie G

4

1 reference

10 September 2017

Skegg DC

5

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

10 September 2017

1 reference

10 September 2017

53

1 reference

10 September 2017

10

1 reference

10 September 2017

903-905

1 reference

Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488255

Frequency of multiple sclerosis in three Australian cities--Perth, Newcastle, and Hobart

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488255

The distribution of multiple sclerosis in the United Kingdom

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488255

Occurrence of multiple sclerosis in the north and south of New Zealand

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488255

Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488255

The contribution of mortality statistics to the study of multiple sclerosis in Australia

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488255

Class II HLA antigens in multiple sclerosis

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488255

HLA and multiple sclerosis in south east Wales

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488255

The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488255

The prevalence of multiple sclerosis in Queensland, Australia. A field survey

15 June 2018

1 reference

12 December 2020

The prevalence of multiple sclerosis in New Zealand

1 reference

12 December 2020

Intravenous paraldehyde for seizure control in newborn infants

1 reference

12 December 2020

The epidemiology of multiple sclerosis in Queensland, Australia

1 reference

12 December 2020

Geographic distribution of MS in New Zealand: evidence from hospital admissions and deaths

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.53.10.903

1 reference

10 September 2017

1 reference

10 September 2017

PubMed publication ID

2266373

1 reference